Primary |
Drug Use For Unknown Indication |
41.7% |
Product Used For Unknown Indication |
27.3% |
Hyperlipidaemia |
8.5% |
Dyslipidaemia |
7.3% |
Hypertension |
3.7% |
Hypertriglyceridaemia |
2.2% |
Hypercholesterolaemia |
1.7% |
Blood Cholesterol Increased |
1.2% |
Type 2 Diabetes Mellitus |
1.1% |
Blood Triglycerides Increased |
1.0% |
Mixed Hyperlipidaemia |
0.7% |
Drug Exposure During Pregnancy |
0.7% |
Diabetes Mellitus |
0.6% |
Depression |
0.5% |
Osteoporosis |
0.3% |
Blood Cholesterol |
0.3% |
Lipids Abnormal |
0.3% |
Pain |
0.3% |
Congestive Cardiomyopathy |
0.3% |
Herpes Zoster |
0.3% |
|
Rhabdomyolysis |
15.3% |
Hepatic Function Abnormal |
11.7% |
Liver Disorder |
11.5% |
High Density Lipoprotein Decreased |
6.8% |
Accidental Exposure |
5.8% |
Renal Failure Acute |
4.9% |
Renal Impairment |
4.9% |
Gamma-glutamyltransferase Increased |
4.0% |
Jaundice |
3.8% |
Liver Function Test Abnormal |
3.6% |
Transaminases Increased |
3.6% |
Myalgia |
3.1% |
Pulmonary Embolism |
3.1% |
Pyrexia |
3.1% |
Rash |
3.1% |
Malaise |
2.9% |
Completed Suicide |
2.6% |
Drug Interaction |
2.0% |
Renal Failure |
2.0% |
Weight Decreased |
2.0% |
|
Secondary |
Product Used For Unknown Indication |
36.1% |
Drug Use For Unknown Indication |
15.9% |
Hypertension |
6.7% |
Blood Cholesterol Increased |
4.9% |
Dyslipidaemia |
4.4% |
Hypercholesterolaemia |
4.4% |
Hyperlipidaemia |
4.4% |
Diabetes Mellitus |
3.7% |
Type 2 Diabetes Mellitus |
3.7% |
Lymphangioma |
2.4% |
Asthma |
2.2% |
Hiv Infection |
2.2% |
Hypertriglyceridaemia |
1.6% |
Blood Triglycerides Increased |
1.6% |
Depression |
1.2% |
Congestive Cardiomyopathy |
1.2% |
Osteoporosis |
1.0% |
Weight Control |
0.8% |
Completed Suicide |
0.8% |
Type Iia Hyperlipidaemia |
0.8% |
|
Myalgia |
10.7% |
High Density Lipoprotein Decreased |
9.2% |
Rhabdomyolysis |
9.2% |
Renal Failure Acute |
8.9% |
Completed Suicide |
8.3% |
Pancreatitis Acute |
7.1% |
White Blood Cell Count Decreased |
5.3% |
Renal Failure |
4.7% |
Vomiting |
4.5% |
Drug Interaction |
4.2% |
Sleep Disorder |
3.9% |
Toxic Epidermal Necrolysis |
3.6% |
Lung Disorder |
3.0% |
Melaena |
3.0% |
Weight Decreased |
3.0% |
Pyrexia |
2.7% |
Thyroid Disorder |
2.7% |
Jaundice |
2.1% |
Liver Function Test Abnormal |
2.1% |
Myositis |
2.1% |
|
Concomitant |
Product Used For Unknown Indication |
32.6% |
Drug Use For Unknown Indication |
20.5% |
Hypertension |
8.4% |
Diabetes Mellitus |
4.5% |
Blood Cholesterol Increased |
4.5% |
Type 2 Diabetes Mellitus |
3.3% |
Depression |
3.2% |
Hiv Infection |
3.2% |
Pain |
2.7% |
Rheumatoid Arthritis |
2.1% |
Blood Triglycerides Increased |
2.0% |
Anxiety |
1.9% |
Hyperlipidaemia |
1.8% |
Atrial Fibrillation |
1.6% |
Hypercholesterolaemia |
1.6% |
Prophylaxis |
1.5% |
Blood Cholesterol |
1.4% |
Gastrooesophageal Reflux Disease |
1.4% |
Insomnia |
1.0% |
Osteoporosis |
1.0% |
|
Flushing |
11.5% |
Vomiting |
11.5% |
Pruritus |
7.5% |
Weight Decreased |
7.3% |
Weight Increased |
6.0% |
Renal Failure Acute |
5.8% |
Nausea |
5.1% |
Drug Ineffective |
4.6% |
Renal Failure |
4.4% |
Myocardial Infarction |
3.9% |
Rash |
3.8% |
Paraesthesia |
3.6% |
Pancreatitis Acute |
3.5% |
Death |
3.4% |
Myalgia |
3.2% |
Pain In Extremity |
3.1% |
Blood Glucose Increased |
3.1% |
Dyspnoea |
3.0% |
Malaise |
3.0% |
Pyrexia |
2.9% |
|
Interacting |
Product Used For Unknown Indication |
16.8% |
Dyslipidaemia |
11.1% |
Hypercholesterolaemia |
11.1% |
Hypertriglyceridaemia |
10.2% |
Deep Vein Thrombosis |
9.8% |
Depression |
7.4% |
Chest Pain |
4.9% |
Hypertension |
4.5% |
Schizophrenia |
3.7% |
Type Iia Hyperlipidaemia |
3.3% |
Atrial Fibrillation |
2.5% |
Drug Use For Unknown Indication |
2.5% |
Pain |
2.5% |
Pain In Extremity |
2.5% |
Coronary Artery Disease |
1.6% |
Immunosuppression |
1.6% |
Lipids Abnormal |
1.6% |
Angina Pectoris |
0.8% |
Blood Triglycerides Increased |
0.8% |
Hyperlipidaemia |
0.8% |
|
Drug Interaction |
32.8% |
High Density Lipoprotein Decreased |
22.4% |
Rhabdomyolysis |
13.4% |
Febrile Neutropenia |
4.5% |
Haemorrhage |
3.0% |
Tremor |
3.0% |
Blood Lactate Dehydrogenase Increased |
1.5% |
Ecchymosis |
1.5% |
Haematuria |
1.5% |
Hypovolaemic Shock |
1.5% |
Myalgia |
1.5% |
Myopathy |
1.5% |
Paraesthesia |
1.5% |
Renal Failure Acute |
1.5% |
Spinal Epidural Haemorrhage |
1.5% |
Spinal Haematoma |
1.5% |
Subcutaneous Haematoma |
1.5% |
Swelling |
1.5% |
Transaminases Increased |
1.5% |
White Blood Cell Count Decreased |
1.5% |
|